We further examined the effect of EGCG on erbB2/Her2 employing HNSCC and breast cancer cell lines, and found that EGCG can inhibit the erbB2/Her2 activation, demonstrating the first example of erbB2/Her2 inhibition by EGCG in human malignancies [32]. This evidence concerns the gene ERBB2 and breast carcinoma.